| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | NUR3DD000103 | Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 01 | 3 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | T9952105 | Value-Based Medical Student Education Training Program | 01 | 3 | HRSA | 11/5/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | NUR3DD000103 | Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 01 | 3 | CDC | 11/10/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | NUR3DD000103 | Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 01 | 3 | CDC | 11/10/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $91,684,057 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | U01DC021719 | Appalachian STAR Trial | 001 | 4 | NIH | 6/9/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | U01DC021719 | Appalachian STAR Trial | 000 | 4 | NIH | 1/21/2025 | $158,896 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | U01DC021719 | Appalachian STAR Trial | 003 | 5 | NIH | 8/25/2025 | $51,258 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | U01DC021719 | Appalachian STAR Trial | 003 | 5 | NIH | 8/25/2025 | $1,173,658 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01AR080736 | Role of Mitochondrial Quality Control in Bone Homeostasis and Disease | 000 | 4 | NIH | 7/17/2025 | $302,940 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R25CA302439 | Cancer and Developing Entrepreneurial Technologies (CADET) | 000 | 1 | NIH | 8/21/2025 | $270,624 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | F30CA305910 | Leveraging the E3 Ligase RNF166 to Prevent T Cell Exhaustion in Solid Tumors | 001 | 1 | NIH | 7/15/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | F30CA305910 | Leveraging the E3 Ligase RNF166 to Prevent T Cell Exhaustion in Solid Tumors | 000 | 1 | NIH | 7/15/2025 | $40,026 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01CA167065 | Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells | 000 | 9 | NIH | 2/28/2025 | $330,851 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01CA167065 | Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells | 001 | 9 | NIH | 4/25/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01CA167065 | Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells | 003 | 9 | NIH | 5/22/2025 | $36,760 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | U0A54981 | Maternal and Child Health Research Consortium | 01 | 1 | HRSA | 9/16/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | U0A54981 | Maternal and Child Health Research Consortium | 00 | 1 | HRSA | 7/28/2025 | $599,999 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R21AI188044 | Single-cell spatial-temporal understanding of the role of macrophage subsets in maintenance of lesion biology and local Mycobacterium tuberculosis infection outcome | 000 | 1 | NIH | 7/23/2025 | $450,500 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | F99CA305484 | Replication Gap Suppression by Translesion Synthesis Promotes Drug Resistance in hard-to-treat cancers | 000 | 1 | NIH | 7/29/2025 | $41,511 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01DK128145 | Evaluation of the effectiveness of Ajjmuurur Baamḷe DSMES in the RMI | 000 | 4 | NIH | 2/17/2025 | $577,482 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01DK135752 | The role of phosphatidic acid in liver regeneration after acetaminophen overdose | 000 | 2 | NIH | 2/20/2025 | $295,231 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01DK135752 | The role of phosphatidic acid in liver regeneration after acetaminophen overdose | 001 | 2 | NIH | 6/18/2025 | $32,803 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R03DE034653 | Role of Macrophage Migration Inhibitory Factor (MIF) in KSHV-associated Malignancies | 000 | 1 | NIH | 7/23/2025 | $306,000 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01AR049794 | Osteocyte Control of Bone Remodeling | 001 | 19 | NIH | 5/9/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01AR049794 | Osteocyte Control of Bone Remodeling | 000 | 19 | NIH | 3/12/2025 | $300,960 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01ES036931 | Understanding the origins of the mutational landscape in cancer | 000 | 1 | NIH | 2/24/2025 | $749,901 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01AG084472 | Neuroinflammation, Protein Aggregates, ApoE4 Drug Targeting, and Autophagy Rescue | 001 | 3 | NIH | 8/4/2025 | $37,628 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01AG084472 | Neuroinflammation, Protein Aggregates, ApoE4 Drug Targeting, and Autophagy Rescue | 000 | 3 | NIH | 2/14/2025 | $423,297 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01HL146713 | T cell homing to the kidney contributes to salt retention and blood pressure regulation | 003 | 7 | NIH | 7/21/2025 | $76,194 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01HL146713 | T cell homing to the kidney contributes to salt retention and blood pressure regulation | 002 | 7 | NIH | 3/28/2025 | $685,749 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01ES032675 | RNA modifications by paternal exposure to arsenic and intergenerational effects on sperm quality | 000 | 4 | NIH | 3/19/2025 | $482,828 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01DE035025 | Epigenetic Regulation of KSHV Latency | 000 | 1 | NIH | 6/25/2025 | $583,289 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R03DA063755 | Novel metabolic pathway for halogenated drugs of abuse | 000 | 1 | NIH | 8/22/2025 | $76,500 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R37CA282349 | Ryanodine Receptors as Therapeutic Targets to Prevent Doxorubicin-Induced Lymphatic Dysfunction | 000 | 3 | NIH | 7/25/2025 | $368,387 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01AR082418 | Antagonism of RANKL signaling by estrogen in osteoclasts | 000 | 2 | NIH | 2/17/2025 | $409,714 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01AG084473 | Role of glucose transport in Alzheimer's disease pathogenesis | 002 | 3 | NIH | 9/4/2025 | -$7,650 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01AG084473 | Role of glucose transport in Alzheimer's disease pathogenesis | 001 | 3 | NIH | 6/13/2025 | $38,250 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R01AG084473 | Role of glucose transport in Alzheimer's disease pathogenesis | 000 | 3 | NIH | 3/4/2025 | $344,250 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | UM1TR004909 | Expanding Translational Science in Arkansas | 002 | 2 | NIH | 9/12/2025 | $214,200 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | UM1TR004909 | Expanding Translational Science in Arkansas | 001 | 2 | NIH | 8/4/2025 | $3,824,629 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R21CA288928 | Mechanisms of Th17-DC immunotherapy for ovarian cancer | 001 | 2 | NIH | 5/22/2025 | $17,881 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R21CA288928 | Mechanisms of Th17-DC immunotherapy for ovarian cancer | 000 | 2 | NIH | 2/14/2025 | $160,938 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | T32DA022981 | Translational Training in Addiction | 003 | 17 | NIH | 6/19/2025 | $7,128 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | T32DA022981 | Translational Training in Addiction | 002 | 17 | NIH | 4/25/2025 | $489,183 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | P20GM103429 | Partnerships for Biomedical Research in Arkansas | 001 | 23 | NIH | 7/25/2025 | $4,290,727 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | F31HL175932 | Kidney-resident memory CD8+ T cells promote hypertension and memorize salt sensitivity. | 000 | 2 | NIH | 9/4/2025 | $39,509 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | K01AT012216 | Harnessing implementation science to study stress management for correctional officers in jail settings | 000 | 2 | NIH | 7/24/2025 | $131,233 |
| | 2025 | 2025 | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205-7101 | PULASKI | USA | R37CA251763 | Bone-Targeted Therapies to Improve Bone Health and Prevent Relapse in Multiple Myeloma | 000 | 6 | NIH | 7/24/2025 | $918,404 |
|
